Zinc Completed Phase 1 Trials for Age Related Macular Degeneration (ARMD) / Neovascular Maculopathy Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00791570Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy